Caduet

Rediff.com » News » Caduet

News for Caduet

Business

Pfizer, Ranbaxy lock horns over Caduet

Ranbaxy Laboratorieson Tuesday stood firm on its strategy of challenging patents, even as Pfizer has filed a suit against it to block the Gurgaon-based firm from going ahead with plans for a......

After Viagra, Indians may pop Caduet

After Viagra, Pfizer is planning bringing another of its blockbuster drugs to India.Caduet, a new generation cardiovascular drug, is a combination of Lipitor (atorvastatin calcium) and Norvasc......

Ranbaxy may get approval for multi-billion dollar drug

The long-awaited US approval for Ranbaxy Laboratories' generic version of anti-hypertension drug Diovan is likely to come this week, according to industry sources.While this could pull the company......

Pfizer, Wyeth sue Ranbaxy over drug

Pfizer, the world's largest drug company, and Wyeth have sued Daiichi Sankyo-owned Ranbaxy Laboratories in a US court for infringing the patent rights of Wyeth's drug, Rapamune.Wyeth and its new......

Indian retail drug sales jump 10% amid slowdown

Retail sales of Ranbaxy Laboratories, Cipla, Nicholas Piramal, Lupin and other drug makers have jumped by over 10 per cent in the domestic market despite the sales of generics or copycat versions......

Videos for Caduet

See All

Web results for Caduet

Ranbaxy plunges 10% on reports Indian govt orders probe

Shares of Ranbaxy Labs tanked more than 10 percent on Thursday amid reports that the Indian Health Ministry has ordered a probe of its own into... ...

http://www.moneycontrol.com/news/business/ranbaxy-plunges-10reports-indian-govt-orders-probe_878830.html

Centrum maintains 'sell' rating on Ranbaxy, target Rs 400

Related to : Ranbaxy Laboratories Ltd Ranbaxy Laboratories Ltd BSE 13 May 13 | 09:37 AM 447.00 -1.95 (-0.43%) NSE 13 May 13 | 09:30 AM 447.25... ...

http://www.smartinvestor.in/market/Marketnews-175674-Marketnewsdet-Centrum_maintains_sell_rating_on_Ranbaxy_target_Rs_400.htm

Ranbaxy net profit plunges 90%

Related to : Ranbaxy Laboratories Ltd Ranbaxy Laboratories Ltd BSE 08 May 13 | 12:00 AM 443.80 -12.7 (-2.78%) NSE 08 May 13 | 12:00 AM 443.85... ...

http://www.smartinvestor.in/market/Compnews-174924-Compnewsdet-Ranbaxy_net_profit_plunges_90.htm

Ranbaxy may get approval for multi-billion dollar drug

The long-awaited US approval for Ranbaxy Laboratories' generic version of anti-hypertension drug Diovan is likely to come this week, according to... ...

http://www.rediff.com/money/report/ranbaxy-may-get-exclusive-rights-for-billion-dollar-drug-diovan1/20130325.htm

See All

Rediff News

Caduet

News for Caduet

Pfizer, Ranbaxy lock horns over Caduet

After Viagra, Indians may pop Caduet

Ranbaxy may get approval for multi-billion dollar drug

Pfizer, Wyeth sue Ranbaxy over drug

Indian retail drug sales jump 10% amid slowdown

Related Tags

Top Coverage News

Indian Premier League - IPL 2013

Coverage: The Match-Fixing Episode II - spot-fixing trial

Sachin Tendulkar : Cup of praise overfloweth - Reactions

Complete coverage of Mumbai blasts

Decoding India’s Corruption Wars - Ajit Balakrishnan's Blog